I am a
Home I AM A Search Login

Papers of the Week

2019 Dec 19

J Gastrointestin Liver Dis


suppl. 4

Budesonide MMX Is Effective in Patients Having Persistent Symptoms and Raised Fecal Calprotectin Following Treatments for Diverticular Disease.


Tursi A, Cassieri C, Colucci R, Elisei W, Picchio M, Brandimarte G
J Gastrointestin Liver Dis. 2019 Dec 19; 28(suppl. 4):45-48.
PMID: 31930223.


Although rifaximin and mesalazine seem to be effective in treating the majority of people suffering from diverticular disease (DD), some patients still experience symptoms following those treatments. The aim of this study was to assess the efficacy of budesonide MMXTM in managing symptoms and raised fecal calprotectin (FC) in patients with endoscopic diagnosis of DD and not responding to standard treatments.